210 related articles for article (PubMed ID: 28388559)
1. Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.
Liu B; Chen F; Wu Y; Wang X; Feng M; Li Z; Zhou M; Wang Y; Wu L; Liu X; Liang D
Oncotarget; 2017 Jun; 8(25):40791-40803. PubMed ID: 28388559
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model.
Wu Z; Liu W; Wang Z; Zeng B; Peng G; Niu H; Chen L; Liu C; Hu Q; Zhang Y; Pan M; Wu L; Liu M; Liu X; Liang D
Cancer Cell Int; 2020; 20():33. PubMed ID: 32015693
[TBL] [Abstract][Full Text] [Related]
3. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
[TBL] [Abstract][Full Text] [Related]
4. Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy.
Wang Z; Chen H; Wang P; Zhou M; Li G; Hu Z; Hu Q; Zhao J; Liu X; Wu L; Liang D
Stem Cells Transl Med; 2022 Mar; 11(3):297-309. PubMed ID: 35267023
[TBL] [Abstract][Full Text] [Related]
5. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.
Hu GW; Li Q; Niu X; Hu B; Liu J; Zhou SM; Guo SC; Lang HL; Zhang CQ; Wang Y; Deng ZF
Stem Cell Res Ther; 2015 Apr; 6(1):10. PubMed ID: 26268554
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
Xu M; Shaw G; Murphy M; Barry F
Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
[TBL] [Abstract][Full Text] [Related]
7. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
Spitzhorn LS; Megges M; Wruck W; Rahman MS; Otte J; Degistirici Ö; Meisel R; Sorg RV; Oreffo ROC; Adjaye J
Stem Cell Res Ther; 2019 Mar; 10(1):100. PubMed ID: 30885246
[TBL] [Abstract][Full Text] [Related]
8. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
Sabapathy V; Kumar S
J Cell Mol Med; 2016 Aug; 20(8):1571-88. PubMed ID: 27097531
[TBL] [Abstract][Full Text] [Related]
9. Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of
Zhao J; Zhou M; Wang Z; Wu L; Hu Z; Liang D
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054807
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of human induced pluripotent stem cell-derived mesenchymal stem cells and umbilical cord mesenchymal stem cells.
Rajasingh S; Sigamani V; Selvam V; Gurusamy N; Kirankumar S; Vasanthan J; Rajasingh J
J Cell Mol Med; 2021 Sep; 25(18):8904-8919. PubMed ID: 34390186
[TBL] [Abstract][Full Text] [Related]
11. Patient-tailored application for Duchene muscular dystrophy on mdx mice based induced mesenchymal stem cells.
Jeong J; Shin K; Lee SB; Lee DR; Kwon H
Exp Mol Pathol; 2014 Oct; 97(2):253-8. PubMed ID: 25102299
[TBL] [Abstract][Full Text] [Related]
12. Genetic barcoding reveals clonal dominance in iPSC-derived mesenchymal stromal cells.
Hollmann J; Brecht J; Goetzke R; Franzen J; Selich A; Schmidt M; Eipel M; Ostrowska A; Hapala J; Fernandez-Rebollo E; Müller-Newen G; Rothe M; Eggermann T; Zenke M; Wagner W
Stem Cell Res Ther; 2020 Mar; 11(1):105. PubMed ID: 32138773
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic antibody directed osteogenic differentiation of induced pluripotent stem cell derived MSCs.
Wu Q; Yang B; Cao C; Hu K; Wang P; Man Y
Acta Biomater; 2018 Jul; 74():222-235. PubMed ID: 29778895
[TBL] [Abstract][Full Text] [Related]
14. Does soft really matter? Differentiation of induced pluripotent stem cells into mesenchymal stromal cells is not influenced by soft hydrogels.
Goetzke R; Franzen J; Ostrowska A; Vogt M; Blaeser A; Klein G; Rath B; Fischer H; Zenke M; Wagner W
Biomaterials; 2018 Feb; 156():147-158. PubMed ID: 29197223
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cells.
Wang Q; Wang Y; Chang C; Ma F; Peng D; Yang S; An Y; Deng Q; Wang Q; Gao F; Wang F; Tang H; Qi X; Jiang X; Cai D; Zhou G
Heliyon; 2023 Jan; 9(1):e12683. PubMed ID: 36647346
[TBL] [Abstract][Full Text] [Related]
16. iPSC-Derived Hereditary Breast Cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
[TBL] [Abstract][Full Text] [Related]
18. Restoration of SMN expression in mesenchymal stem cells derived from gene-targeted patient-specific iPSCs.
Feng M; Liu C; Xia Y; Liu B; Zhou M; Li Z; Sun Q; Hu Z; Wang Y; Wu L; Liu X; Liang D
J Mol Histol; 2018 Feb; 49(1):27-37. PubMed ID: 29209912
[TBL] [Abstract][Full Text] [Related]
19. Fn14 promotes differentiation of human mesenchymal stem cells into heart valvular interstitial cells by phenotypic characterization.
Huang W; Xiao DZ; Wang Y; Shan ZX; Liu XY; Lin QX; Yang M; Zhuang J; Li Y; Yu XY
J Cell Physiol; 2014 May; 229(5):580-7. PubMed ID: 24122208
[TBL] [Abstract][Full Text] [Related]
20. Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA.
Umrath F; Steinle H; Weber M; Wendel HP; Reinert S; Alexander D; Avci-Adali M
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
